DY
Difei Yang Mizuho Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
Akebia Therapeutics
AKBA
$827M
| $3.12 | $2 |
36%
downside
| Neutral | 3 years ago |
|
2 |
2
NovoCure
NVCR
$1.35B
| $12.08 | $200 |
1,556%
upside
| Neutral | 4 years ago |
|
3 |
3
uniQure
QURE
$954M
| $17.38 | $52 |
199%
upside
| Buy | 4 years ago |
|
4 |
4
Sarepta Therapeutics
SRPT
$1.98B
| $18.95 | $160 |
744%
upside
| Buy | 4 years ago |
|
5 |
5
Xeris Biopharma Holdings
XERS
$1.27B
| $7.84 | $14 |
79%
upside
| Buy | 5 years ago |
|
6 |
6
Nektar Therapeutics
NKTR
$543M
| $28.55 | $525 |
1,739%
upside
| Buy | 5 years ago |
|